世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ウィメンズヘルス治療薬の世界市場 2022-2026


Global Women's Health Therapeutics Market 2022-2026

女性の健康治療薬の世界市場2022-2026年 Technavioは女性の健康治療薬市場を監視しており、2022-2026年の間に303億5000万ドルの成長が見込まれ、予測期間中にCAGR 5.74%で加速しています。女性の健康治療薬市場... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年8月30日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報・注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

女性の健康治療薬の世界市場2022-2026年
Technavioは女性の健康治療薬市場を監視しており、2022-2026年の間に303億5000万ドルの成長が見込まれ、予測期間中にCAGR 5.74%で加速しています。女性の健康治療薬市場に関する当レポートでは、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は戦略的提携によって牽引されています。
女性の健康治療薬市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの女性の健康治療薬市場は、以下のように区分されています。
タイプ別
- 妊産婦
- オンコロジー
- 更年期障害
- 感染症
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域(ROW)
本調査では、婦人科疾患に対する意識の高まりが、今後数年間における女性の健康治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、新しい治療法の出現と抗生物質耐性に対する政府の取り組みの高まりは、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な図を提示します。女性の健康治療薬市場に関する当レポートは、以下の分野を対象としています。
- 女性の健康治療薬市場のサイジング
- 女性の健康に関する治療薬市場の予測
- 女性の健康治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abbott Laboratories、AbbVie Inc.を含むいくつかの主要な女性の健康治療薬市場のベンダーについて詳細な分析を提供しています。アムジェン、バイエル、イーライリリー、ホフマン・ラ・ロシュ、GLSファーマ、アイコン、メルク、ノバルティス、ノボノルディスク、オブセバ、ファイザー、ラディウス、サノフィ、武田薬品工業、テバ・ファーマシューティカル・インダストリーズなどです。Ltd.、Teva Pharmaceutical Industries Ltd.、TSUMURA and Co.、Vivesto AB、Mithra Pharmaceuticals SAが含まれます。また、女性の健康治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報および二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/women-s-health-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Fertility - Market size and forecast 2021-2026
o Exhibit 28: Chart on Fertility - Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on Fertility - Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on Fertility - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Fertility - Year-over-year growth 2021-2026 (%)
o 5.4 Oncology - Market size and forecast 2021-2026
o Exhibit 32: Chart on Oncology - Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on Oncology - Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
o 5.5 Menopause - Market size and forecast 2021-2026
o Exhibit 36: Chart on Menopause - Market size and forecast 2021-2026 ($ billion)
o Exhibit 37: Data Table on Menopause - Market size and forecast 2021-2026 ($ billion)
o Exhibit 38: Chart on Menopause - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Menopause - Year-over-year growth 2021-2026 (%)
o 5.6 Infection - Market size and forecast 2021-2026
o Exhibit 40: Chart on Infection - Market size and forecast 2021-2026 ($ billion)
o Exhibit 41: Data Table on Infection - Market size and forecast 2021-2026 ($ billion)
o Exhibit 42: Chart on Infection - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Infection - Year-over-year growth 2021-2026 (%)
o 5.7 Others - Market size and forecast 2021-2026
o Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
o Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
o Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Type
o Exhibit 48: Market opportunity by Type ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 97: Abbott Laboratories - Overview
o Exhibit 98: Abbott Laboratories - Business segments
o Exhibit 99: Abbott Laboratories - Key news
o Exhibit 100: Abbott Laboratories - Key offerings
o Exhibit 101: Abbott Laboratories - Segment focus
o 10.4 AbbVie Inc.
o Exhibit 102: AbbVie Inc. - Overview
o Exhibit 103: AbbVie Inc. - Product / Service
o Exhibit 104: AbbVie Inc. - Key offerings
o 10.5 Amgen Inc.
o Exhibit 105: Amgen Inc. - Overview
o Exhibit 106: Amgen Inc. - Product / Service
o Exhibit 107: Amgen Inc. - Key offerings
o 10.6 Bayer AG
o Exhibit 108: Bayer AG - Overview
o Exhibit 109: Bayer AG - Business segments
o Exhibit 110: Bayer AG - Key offerings
o Exhibit 111: Bayer AG - Segment focus
o 10.7 Eli Lilly and Co.
o Exhibit 112: Eli Lilly and Co. - Overview
o Exhibit 113: Eli Lilly and Co. - Product / Service
o Exhibit 114: Eli Lilly and Co. - Key offerings
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 115: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 116: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 117: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 118: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 119: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 ICON plc
o Exhibit 120: ICON plc - Overview
o Exhibit 121: ICON plc - Product / Service
o Exhibit 122: ICON plc - Key offerings
o 10.10 Merck KGaA
o Exhibit 123: Merck KGaA - Overview
o Exhibit 124: Merck KGaA - Business segments
o Exhibit 125: Merck KGaA - Key news
o Exhibit 126: Merck KGaA - Key offerings
o Exhibit 127: Merck KGaA - Segment focus
o 10.11 Mithra Pharmaceuticals SA
o Exhibit 128: Mithra Pharmaceuticals SA - Overview
o Exhibit 129: Mithra Pharmaceuticals SA - Product / Service
o Exhibit 130: Mithra Pharmaceuticals SA - Key offerings
o 10.12 Novartis AG
o Exhibit 131: Novartis AG - Overview
o Exhibit 132: Novartis AG - Business segments
o Exhibit 133: Novartis AG - Key offerings
o Exhibit 134: Novartis AG - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 135: Inclusions checklist
o Exhibit 136: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 137: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 138: Research methodology
o Exhibit 139: Validation techniques employed for market sizing
o Exhibit 140: Information sources
o 11.5 List of abbreviations
o Exhibit 141: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Fertility - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Fertility - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Menopause - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Menopause - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibits41: Data Table on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibits42: Chart on Infection - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Infection - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Type ($ billion)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories - Overview
Exhibits98: Abbott Laboratories - Business segments
Exhibits99: Abbott Laboratories - Key news
Exhibits100: Abbott Laboratories - Key offerings
Exhibits101: Abbott Laboratories - Segment focus
Exhibits102: AbbVie Inc. - Overview
Exhibits103: AbbVie Inc. - Product / Service
Exhibits104: AbbVie Inc. - Key offerings
Exhibits105: Amgen Inc. - Overview
Exhibits106: Amgen Inc. - Product / Service
Exhibits107: Amgen Inc. - Key offerings
Exhibits108: Bayer AG - Overview
Exhibits109: Bayer AG - Business segments
Exhibits110: Bayer AG - Key offerings
Exhibits111: Bayer AG - Segment focus
Exhibits112: Eli Lilly and Co. - Overview
Exhibits113: Eli Lilly and Co. - Product / Service
Exhibits114: Eli Lilly and Co. - Key offerings
Exhibits115: F. Hoffmann La Roche Ltd. - Overview
Exhibits116: F. Hoffmann La Roche Ltd. - Business segments
Exhibits117: F. Hoffmann La Roche Ltd. - Key news
Exhibits118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits119: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits120: ICON plc - Overview
Exhibits121: ICON plc - Product / Service
Exhibits122: ICON plc - Key offerings
Exhibits123: Merck KGaA - Overview
Exhibits124: Merck KGaA - Business segments
Exhibits125: Merck KGaA - Key news
Exhibits126: Merck KGaA - Key offerings
Exhibits127: Merck KGaA - Segment focus
Exhibits128: Mithra Pharmaceuticals SA - Overview
Exhibits129: Mithra Pharmaceuticals SA - Product / Service
Exhibits130: Mithra Pharmaceuticals SA - Key offerings
Exhibits131: Novartis AG - Overview
Exhibits132: Novartis AG - Business segments
Exhibits133: Novartis AG - Key offerings
Exhibits134: Novartis AG - Segment focus
Exhibits135: Inclusions checklist
Exhibits136: Exclusions checklist
Exhibits137: Currency conversion rates for US$
Exhibits138: Research methodology
Exhibits139: Validation techniques employed for market sizing
Exhibits140: Information sources
Exhibits141: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Women's Health Therapeutics Market 2022-2026
Technavio has been monitoring the women's health therapeutics market and it is poised to grow by $ 30.35 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period. Our report on the women's health therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strategic alliances.
The women's health therapeutics market analysis includes the type segment and geographic landscape.
Technavio's women's health therapeutics market is segmented as below:
By Type
• Fertility
• Oncology
• Menopause
• Infection
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the rising awareness of gynecological diseases as one of the prime reasons driving the women's health therapeutics market growth during the next few years. Also, the emergence of novel therapies and rising government initiatives for antibiotic resistance will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on women's health therapeutics market covers the following areas:
• Women's health therapeutics market sizing
• Women's health therapeutics market forecast
• Women's health therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading women's health therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA. Also, the women's health therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/women-s-health-therapeutics-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Fertility - Market size and forecast 2021-2026
o Exhibit 28: Chart on Fertility - Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on Fertility - Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on Fertility - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Fertility - Year-over-year growth 2021-2026 (%)
o 5.4 Oncology - Market size and forecast 2021-2026
o Exhibit 32: Chart on Oncology - Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on Oncology - Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
o 5.5 Menopause - Market size and forecast 2021-2026
o Exhibit 36: Chart on Menopause - Market size and forecast 2021-2026 ($ billion)
o Exhibit 37: Data Table on Menopause - Market size and forecast 2021-2026 ($ billion)
o Exhibit 38: Chart on Menopause - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Menopause - Year-over-year growth 2021-2026 (%)
o 5.6 Infection - Market size and forecast 2021-2026
o Exhibit 40: Chart on Infection - Market size and forecast 2021-2026 ($ billion)
o Exhibit 41: Data Table on Infection - Market size and forecast 2021-2026 ($ billion)
o Exhibit 42: Chart on Infection - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Infection - Year-over-year growth 2021-2026 (%)
o 5.7 Others - Market size and forecast 2021-2026
o Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
o Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
o Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Type
o Exhibit 48: Market opportunity by Type ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 97: Abbott Laboratories - Overview
o Exhibit 98: Abbott Laboratories - Business segments
o Exhibit 99: Abbott Laboratories - Key news
o Exhibit 100: Abbott Laboratories - Key offerings
o Exhibit 101: Abbott Laboratories - Segment focus
o 10.4 AbbVie Inc.
o Exhibit 102: AbbVie Inc. - Overview
o Exhibit 103: AbbVie Inc. - Product / Service
o Exhibit 104: AbbVie Inc. - Key offerings
o 10.5 Amgen Inc.
o Exhibit 105: Amgen Inc. - Overview
o Exhibit 106: Amgen Inc. - Product / Service
o Exhibit 107: Amgen Inc. - Key offerings
o 10.6 Bayer AG
o Exhibit 108: Bayer AG - Overview
o Exhibit 109: Bayer AG - Business segments
o Exhibit 110: Bayer AG - Key offerings
o Exhibit 111: Bayer AG - Segment focus
o 10.7 Eli Lilly and Co.
o Exhibit 112: Eli Lilly and Co. - Overview
o Exhibit 113: Eli Lilly and Co. - Product / Service
o Exhibit 114: Eli Lilly and Co. - Key offerings
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 115: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 116: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 117: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 118: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 119: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 ICON plc
o Exhibit 120: ICON plc - Overview
o Exhibit 121: ICON plc - Product / Service
o Exhibit 122: ICON plc - Key offerings
o 10.10 Merck KGaA
o Exhibit 123: Merck KGaA - Overview
o Exhibit 124: Merck KGaA - Business segments
o Exhibit 125: Merck KGaA - Key news
o Exhibit 126: Merck KGaA - Key offerings
o Exhibit 127: Merck KGaA - Segment focus
o 10.11 Mithra Pharmaceuticals SA
o Exhibit 128: Mithra Pharmaceuticals SA - Overview
o Exhibit 129: Mithra Pharmaceuticals SA - Product / Service
o Exhibit 130: Mithra Pharmaceuticals SA - Key offerings
o 10.12 Novartis AG
o Exhibit 131: Novartis AG - Overview
o Exhibit 132: Novartis AG - Business segments
o Exhibit 133: Novartis AG - Key offerings
o Exhibit 134: Novartis AG - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 135: Inclusions checklist
o Exhibit 136: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 137: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 138: Research methodology
o Exhibit 139: Validation techniques employed for market sizing
o Exhibit 140: Information sources
o 11.5 List of abbreviations
o Exhibit 141: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Fertility - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Fertility - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Menopause - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Menopause - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibits41: Data Table on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibits42: Chart on Infection - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Infection - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Type ($ billion)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories - Overview
Exhibits98: Abbott Laboratories - Business segments
Exhibits99: Abbott Laboratories - Key news
Exhibits100: Abbott Laboratories - Key offerings
Exhibits101: Abbott Laboratories - Segment focus
Exhibits102: AbbVie Inc. - Overview
Exhibits103: AbbVie Inc. - Product / Service
Exhibits104: AbbVie Inc. - Key offerings
Exhibits105: Amgen Inc. - Overview
Exhibits106: Amgen Inc. - Product / Service
Exhibits107: Amgen Inc. - Key offerings
Exhibits108: Bayer AG - Overview
Exhibits109: Bayer AG - Business segments
Exhibits110: Bayer AG - Key offerings
Exhibits111: Bayer AG - Segment focus
Exhibits112: Eli Lilly and Co. - Overview
Exhibits113: Eli Lilly and Co. - Product / Service
Exhibits114: Eli Lilly and Co. - Key offerings
Exhibits115: F. Hoffmann La Roche Ltd. - Overview
Exhibits116: F. Hoffmann La Roche Ltd. - Business segments
Exhibits117: F. Hoffmann La Roche Ltd. - Key news
Exhibits118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits119: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits120: ICON plc - Overview
Exhibits121: ICON plc - Product / Service
Exhibits122: ICON plc - Key offerings
Exhibits123: Merck KGaA - Overview
Exhibits124: Merck KGaA - Business segments
Exhibits125: Merck KGaA - Key news
Exhibits126: Merck KGaA - Key offerings
Exhibits127: Merck KGaA - Segment focus
Exhibits128: Mithra Pharmaceuticals SA - Overview
Exhibits129: Mithra Pharmaceuticals SA - Product / Service
Exhibits130: Mithra Pharmaceuticals SA - Key offerings
Exhibits131: Novartis AG - Overview
Exhibits132: Novartis AG - Business segments
Exhibits133: Novartis AG - Key offerings
Exhibits134: Novartis AG - Segment focus
Exhibits135: Inclusions checklist
Exhibits136: Exclusions checklist
Exhibits137: Currency conversion rates for US$
Exhibits138: Research methodology
Exhibits139: Validation techniques employed for market sizing
Exhibits140: Information sources
Exhibits141: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05 10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る